Jessica Hagen, Author at

Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the

Hollywood and the Metaverse’s effect on pharma’s content

https://pharmaphorum.com/views-and-analysis/hollywood-and-the-metaverses-effect-on-pharmas-content/

Digital/ Views & Analysis/ Views and analysis

The NIH on accelerating research using diverse biomedical datasets

Jessica Hagen All of Us, biomedical research, biosamples, data, diversity, mobile engagement asset, NIH, personalised medicine 0 Comment

Martin Mendoza, PhD, director of health equity and health science policy for the All of Us Research Program

The NIH on accelerating research using diverse biomedical datasets

https://pharmaphorum.com/views-and-analysis/the-nih-on-accelerating-research-using-diverse-biomedical-datasets/

News/ R&D/ Views & Analysis/ Views and analysis

Reconfiguring COVID and influenza vaccines for long-term effectiveness

Jessica Hagen COVID-19, flu, influenza, nucleoprotein, oligoDOM, Osivax, T-cells, technology, vaccines, viruses 0 Comment

Alexandre Le Vert, CEO and co-founder of Osivax, discusses the company’s breakthrough vaccine technology, oligoDOM, and how it’s

Reconfiguring COVID and influenza vaccines for long-term effectiveness

https://pharmaphorum.com/r-d/reconfiguring-covid-and-influenza-vaccines-for-long-term-effectiveness/

Insights/ Oncology/ Patients/ Views and analysis

The use of genomic profiling testing to improve oncology care

Jessica Hagen cancer care, cells, genomic profiling, genomics, Labcorp, liquid biopsy, MD Anderson, Oncology 0 Comment

Dr Prasanth Reddy, head of oncology at Labcorp, tells us how the company works with cancer care teams,

The use of genomic profiling testing to improve oncology care

https://pharmaphorum.com/views-and-analysis/the-use-of-genomic-profiling-testing-to-improve-oncology-care/

Digital/ Views & Analysis/ Views and analysis

The discovery of a new and compounding cybersecurity threat to pharmacies

Jessica Hagen cybersecurity, digital pharmacies, Kasada, opioid crisis, pharmacies, prescriptions 0 Comment

Sam Crowther, founder and CEO of cybersecurity company Kasada, tells us about a recent discovery his company made

The discovery of a new and compounding cybersecurity threat to pharmacies

https://pharmaphorum.com/views-and-analysis/the-discovery-of-a-new-and-compounding-cybersecurity-threat-to-pharmacies/

Market Access/ Views & Analysis/ Views and analysis

Dr. B: Expanding the business model from COVID vaccines to antiviral medications

Jessica Hagen access to medication, antivirals, Dr B, market access, pharma, vaccines 0 Comment

Cyrus Massoumi, founder of Dr. B, tells us about his online platform that makes physician assessment readily available

Dr. B: Expanding the business model from COVID vaccines to antiviral medications

https://pharmaphorum.com/views-and-analysis/dr-b-expanding-the-business-model-from-covid-vaccines-to-antiviral-medications/

Health Innovation Fund, Moderna’s largest shareholder, shares investment strategies

Digital/ Views & Analysis/ Views and analysis

Baillie Gifford, Moderna’s largest shareholder, shares investment strategies

Jessica Hagen Broad Institue, Health Innovation Fund, Moderna, mRNA 0 Comment

Jack Torrance, investment specialist for Baillie Gifford’s Health Innovation Fund, tells us how the organisation ensures its investments

Baillie Gifford, Moderna’s largest shareholder, shares investment strategies

https://pharmaphorum.com/digital/health-innovation-fund-modernas-largest-shareholder-shares-investment-strategies/

Smiling african american woman using vr headset at work

Digital/ Views & Analysis/ Views and analysis

Evidence-backed VR therapy helps patients overcome phobias

Jessica Hagen Oculus Quest, oVRcome, virtual reality, VR therapy 0 Comment

Adam Hutchinson, founder of oVRcome, discusses the weight the New Zealand-based company places on ensuring the accuracy and

Evidence-backed VR therapy helps patients overcome phobias

https://pharmaphorum.com/views-and-analysis/evidence-backed-vr-therapy-helps-patients-overcome-phobias/

Patients/ Views & Analysis/ Views and analysis

Living the life of a type 2 diabetes patient for a day

Jessica Hagen Diabetes, patient centricity, The Method, Type 2 diabetes 0 Comment

Mark Doyle, co-founder of The Method and creator of the A Life in a Day programme, tells us

Living the life of a type 2 diabetes patient for a day

https://pharmaphorum.com/patients/living-the-life-of-a-type-2-diabetes-patient-for-a-day/

Trending

About Jessica Hagen

Posts by Jessica Hagen:

Hollywood and the Metaverse’s effect on pharma’s content

The NIH on accelerating research using diverse biomedical datasets

Reconfiguring COVID and influenza vaccines for long-term effectiveness

The use of genomic profiling testing to improve oncology care

The discovery of a new and compounding cybersecurity threat to pharmacies

Dr. B: Expanding the business model from COVID vaccines to antiviral medications

Baillie Gifford, Moderna’s largest shareholder, shares investment strategies

Evidence-backed VR therapy helps patients overcome phobias

Living the life of a type 2 diabetes patient for a day

Trending

About Jessica Hagen

Posts by Jessica Hagen:

Login